SCHEMBL13817293

SCHEMBL13817293

CC1(Cc2ccc(Br)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(S(C)(=O)=O)n21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 20/20 1.00
ICAM1 P05362 20/20 1.00
ITGAL P20701 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13816990 1.00 ITGB2 (1.00) ITGB2ICAM1ITGAL
SCHEMBL4017369 0.92 ITGB2 (0.85) ITGB2ICAM1ITGAL
SCHEMBL4017365 0.92 ITGB2 (0.85) ITGB2ICAM1ITGAL
SCHEMBL13817169 0.91 ITGB2 (0.84) ITGB2ICAM1ITGAL
SCHEMBL13817166 0.91 ITGB2 (0.84) ITGB2ICAM1ITGAL
SCHEMBL13817161 0.89 ITGB2 (0.81) ITGB2ICAM1ITGAL
SCHEMBL13817107 0.89 ITGB2 (0.81) ITGB2ICAM1ITGAL
SCHEMBL13817194 0.89 ITGB2 (0.84) ITGB2ICAM1ITGAL
SCHEMBL13817158 0.89 ITGB2 (0.79) ITGB2ICAM1ITGAL
SCHEMBL13817329 0.89 ITGB2 (1.00) ITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550494-B2 Small molecules useful in the treatment of inflammatory disease BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-06-23 US disclosed
US-7550494-B2 Small molecules useful in the treatment of inflammatory disease BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-06-23 US disclosed
EP-1216247-B1 IMIDAZOIMIDAZOLES AND TRIAZOLES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMA (US) 2008-11-05 EP disclosed